We received back the results of Tom's Prostate Biopsy and they did identify cancer in 3/15 core samples taken. The doctors ...

The prospective, multi-center phase 3 PRIMARY randomized trial tested the additive diagnostic value of PSMA PET imaging in high-risk men with negative or equivocal MRI in the diagnosis of significant ...

Profound Medical (PROF) announced superiority on the prespecified, primary safety endpoint in the Level 1 post-market CAPTAIN ...

Transdermal estradiol offers fewer hot flashes and lower fracture rates, but higher rates of gynecomastia, as it meets the ...

A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...

The trial design for ARASTEP is highlighted in the following schema: Two special considerations for ARASTEP are that all patients have maximally treated pelvic disease and that metastasis directed ...

The 2026 PSMA & Beyond conference featured a targeting the cell surface session and presentation by Dr. Rahul Aggarwal discussing DLL3 and whether target expression determines the method of targeting.

A systematic review of 29,941 patients shows that preoperative MRI findings significantly improve risk stratification for men with prostate cancer undergoing radical prostatectomy.

A new study indicated that the Bellmunt Risk Score can help stratify survival outcomes in patients with metastatic castration-resistant prostate cancer. Using data from more than 1700 patients across ...

Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...

An MRI before treatment in men undergoing radical prostatectomy can provide independent prognostic value for oncologic ...